Early Introduction of Cenobamate in Uncontrolled Focal Epilepsy: Insights from a Structured Controversy
Abstract Introduction Drug-resistant focal epilepsy, as defined by the International League Against Epilepsy (ILAE), is characterized by the failure to achieve seizure control despite the use of at least two appropriately chosen and adequately dosed antiseizure medications (ASMs). This condition aff...
Saved in:
| Main Authors: | Angelo Labate, Claudio Liguori, Elena Tartara, Gemma Tumminelli, Annacarmen Nilo, Marta Piccioli, Filippo Dainese, Luigi Del Gaudio, Carlo Di Bonaventura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-06-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40120-025-00781-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world utilization of Cenobamate as adjunct therapy in office-based neurology: practical tips and insights for titration
by: Patrick M. House, et al.
Published: (2025-06-01) -
Cost-effectiveness of cenobamate as a therapeutic alternative for the treatment of focal epilepsy in adults with inadequate seizure control
by: Martina Paoletti, et al.
Published: (2025-05-01) -
Terminology of medicines used to control seizure disorders: 2024 ILAE Recommendations and profile of real-world term use
by: D. V. Blinov, et al.
Published: (2024-10-01) -
Cenobamate for Adjunctive Treatment in Adult and Pediatric Patients with Refractory Lennox–Gastaut Syndrome: A Retrospective Chart Review
by: Karen Keough, et al.
Published: (2025-06-01) -
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
by: Simona Lattanzi, et al.
Published: (2025-03-01)